Skip to main content
OpenTrials
Completed

NCT Number: NCT00807508

Leucine Supplementation in Elderly Men

In the present study the investigators aim to determine whether leucine supplementation can augment muscle mass and strength and improve body composition in healthy elderly men

Completed

Looking for future studies?

Notify Me

Key information

Age range

65 year–85 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Maastricht University Medical Centre

Maastricht, 6200 MD, Netherlands

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • living independently

Exclusion criteria

  • Diabetes cardiovascular disease orthopedic limitations history of resistance training in past 5 years

Treatment and study plan

Placebo

Dietary Supplement

wheat meal capsules with each main meal

Leucine

Dietary Supplement

daily leucine capsules with each main meal

Primary outcomes

  1. muscle mass and body composition

    Time frame: before and after 12 wk intervention

Secondary outcomes

  1. muscle strength

    Time frame: before and after 12 wk intervention

Sponsors and collaborators

Lead sponsor

Maastricht University Medical Center

Other

Registry information

Official study title

The Influence of Leucine Supplementation on Body Composition and Muscle Characteristics in Healthy Elderly

Important dates

Study start
2007
Primary completion
2007
Study completion
2008
First posted
Dec 12, 2008
Registry last updated
Dec 12, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.